General
Preferred name
L-365260
Synonyms
L-365,260 ()
2016-06-07: L 365260 ()
LY-365260 ()
P&D ID
PD070653
CAS
118101-09-0
Tags
drug candidate
natural product
probe
available
Drug indication
Anxiety disorder
Probe info
Probe selectivity
protein-selective
Probe type
P&D approved
calculated probe
experimental probe
Probe targets
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
MOA Antagonist (Chemical Probes.org)
DESCRIPTION Selective CCR1 antagonist (Tocris Bioactive Compound Library)
DESCRIPTION L-365,260 is a nonpeptide cholecystokinin receptor 2 (CCK2/CCKB) antagonist. It selectively binds to gastrin and CCK2 sites to reduce basal acid secretion, and prevent gastrointestinal damage in models of peptic ulcer disease. (BOC Sciences Bioactive Compounds)
Cell lines
1
Organisms
0
Compound Sets
11
BOC Sciences Bioactive Compounds
Chemical Probes.org
Drug Repurposing Hub
DrugMAP
EUbOPEN Chemogenomics Library
High-quality chemical probes
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
Probe Miner (suitable probes)
ReFrame library
Tocris Bioactive Compound Library
External IDs
18
Properties
(calculated by RDKit )
Molecular Weight
398.17
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
3
Ring Count
4
Aromatic Ring Count
3
cLogP
3.96
TPSA
73.8
Fraction CSP3
0.12
Chiral centers
1.0
Largest ring
7.0
QED
0.7
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Primary Target
CCK2 Receptors
MOA
Antagonist
CCK2 (CCKB/Gastrin) Antagonists
CCK receptor antagonist
Member status
member
Target
CCKAR, CCKBR, KCNQ1
Cholecystokinin Receptor
CCKBR
Pathway
GPCR/G protein
Neuronal Signaling
Target class
GPCR
Control
CANSAR236284
Source data